Tenderwize
Retour à la recherche

Open house Pharmaceutical Discount Agreements Iron(III)-Derisomaltose, ATC B03AC08

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline May 05, 2027 · 249 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Eisen(III)-Derisomaltose, ATC B03AC08

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

No estimated value or framework maximum is provided. The actual volume of business under these agreements is unknown, m...

Contracts automatically terminate if a national or regional discount agreement for the same active ingredient enters in...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Conclusion of non-exclusive discount agreements (Rabattverträge) for the active ingredient Iron(III)-derisomaltose (ATC B03AC08) with AOK Bayern
  • Agreements are identical for all participants, not individually negotiated
Afficher le résumé complet

Open-house model for non-exclusive pharmaceutical discount agreements (Rabattverträge) for the active ingredient Iron(III)-derisomaltose (ATC B03AC08) offered by AOK Bayern. The procedure is not a public procurement but a voluntary open-house model open to all qualified pharmaceutical companies. Contracts run from 01.07.2025 to 30.06.2027, with possible termination if other discount agreements come into effect. No estimated value is provided.

Risques

No estimated value or framework maximum is provided. The actual volume of business under these agreements is unknown, m...

Contracts automatically terminate if a national or regional discount agreement for the same active ingredient enters in...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Signed contract including attachment 'Festlegung der vertragsgegenständlichen Arzneimittel'

Eligibility

  • Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible

Administrative

  • Submission of signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit)

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Not applicable (open-house model, no award criteria; all eligible participants are accepted)

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house Pharmaceutical Discount Agreements Iron(III)-Derisomaltose, ATC B03AC08

Non-exclusive discount agreements for the active ingredient Iron(III)-derisomaltose for the region of Bavaria. Open to all pharmaceutical companies meeting eligibility criteria. Contracts can be concluded at any time until 05.05.2027, with start dates aligned to the first of the month after submission.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Jun 2025 - Jun 2027

Catégorie

Pharmaceutical products

Critères d'attribution

Not applicable (open-house model, no award criteria; all eligible participants are accepted)

Date limite

Deadline May 05, 2027

Détails de la procédure

Date de publication
15 May 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
316847-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30